Cognitive dysfunction in mitochondrial disorders

Acta Neurologica Scandinavica

Volumn 126, Issue 1, 2012, Pages 1-11

  Finsterer, J ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

Central nervous system involvement; Cognitive impairment; Cognitive regression; Dementia; Encephalopathy; Mental retardation; Mitochondrial disorder

Indexed keywords

AMINOGLYCOSIDE; ARGININE; CELL NUCLEUS DNA; CREATINE; CYCLOSPORIN; DICHLOROACETIC ACID; DIMETHYLGLYCINE; MITOCHONDRIAL DNA; PROPOFOL; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TETRACYCLINE; VALPROIC ACID;

ACUTE RESPIRATORY FAILURE; ATAXIA; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COGNITIVE DEFECT; CONFUSION; DELIRIUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROENCEPHALOGRAM; EPILEPSY; EXTERNAL OPHTHALMOPLEGIA; HEART FAILURE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOGONADISM; IMMUNOHISTOCHEMISTRY; KEARNS SAYRE SYNDROME; KIDNEY FAILURE; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LEIGH DISEASE; LIVER FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; MATERNALLY INHERITED DIABETES AND DEAFNESS; MELAS SYNDROME; MIGRAINE; MITOCHONDRIAL ENCEPHALOPATHY; MOTOR RETARDATION; MUSCLE FUNCTION; MYOCLONUS EPILEPSY; NEUROIMAGING; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; OPTIC NERVE ATROPHY; PANCYTOPENIA; PARANOIA; PARKINSON DISEASE; PSYCHOSIS; PTOSIS; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; RETINITIS PIGMENTOSA; REVIEW; RHABDOMYOLYSIS; SPINOCEREBELLAR DEGENERATION; WOLF HIRSCHHORN SYNDROME; WOLFRAM SYNDROME;

COGNITION; COGNITION DISORDERS; HUMANS; MITOCHONDRIAL DISEASES;

EID: 84861933407     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01649.x     Document Type: Review

References (51)

1. McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet Neurol 2010;9:829-40.
2. Finsterer J, Jarius C, Eichberger H. Phenotype variability in 130 adult patients with respiratory chain disorders. J Inherit Metab Dis 2001;24:560-76.
3. Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand 2006;114:217-38.
4. Finsterer J. Psychosis as a manifestation of cerebral involvement in mitochondrial disorders. In: Anninos P, Rossi M, Pham TD, Falugi C, Bussing A, Koukkou M, eds. Recent advances in clinical medicine. Proceedings of the International Conferences on Medical Pharmacology/Medical Histology and Embryology/Psychiatry and Psychotherapy/International Conference on Oncology, Cambridge, UK: University of Cambridge, February, Recent Adv Clin Med 2010;90-6.
5. Fromont I, Nicoli F, Valéro R et al.Brain anomalies in maternally inherited diabetes and deafness syndrome. J Neurol 2009;256:1696-704.
6. Kaufman KR, Zuber N, Rueda-Lara MA, Tobia A. MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioural disturbances: case analysis with literature review. Epilepsy Behav 2010;18:494-7.
7. Lindberg C, Moslemi AR, Oldfors A. MELAS syndrome in a patient with a point mutation in MTTS1. Acta Neurol Scand 2008;117:128-32.
8. Salsano E, Giovagnoli AR, Morandi L et al.Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation. J Neurol Sci 2011;300:165-8.
9. Sartor H, Loose R, Tucha O, Klein HE, Lange KW. MELAS: a neuropsychological and radiological follow-up study. Mitochondrial encephalomyopathy, lactic acidosis and stroke. Acta Neurol Scand 2002;106:309-13.
10. Sharfstein SR, Gordon MF, Libman RB, Malkin ES. Adult-onset MELAS presenting as herpes encephalitis. Arch Neurol 1999;56:241-3.
11. Sparaco M, Simonati A, Cavallaro T et al.MELAS: clinical phenotype and morphological brain abnormalities. Acta Neuropathol 2003;106:202-12.
12. Stratilová L, Zeman J, Houst'ková H et al.Various manifestations of the A8344G mtDNA heteroplasmic mutation in 4 families with the MERRF syndrome. Cas Lek Cesk 1999;138:401-5.
13. Turconi AC, Benti R, Castelli E et al.Focal cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study. J Neurol Sci 1999;170:57-63.
14. Bosbach S, Kornblum C, Schröder R, Wagner M. Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Brain 2003;126:1231-40.
15. Mäkelä-Bengs P, Suomalainen A, Majander A et al.Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatr Res 1995;37:634-9.
16. Coku J, Shanske S, Mehrazin M et al.Slowly progressive encephalopathy with hearing loss due to a mutation in the mtDNAtRNA(Leu(CUN)) gene. J Neurol Sci 2010;290:166-8.
17. Deschauer M, Bamberg C, Claus D, Zierz S, Turnbull DM, Taylor RW. Late-onset encephalopathy associated with a C11777A mutation of mitochondrial DNA. Neurology 2003;60:1357-9.
18. Graf WD, Marin-Garcia J, Gao HG et al.Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol 2000;15:357-61.
19. Jaksch M, Lochmuller H, Schmitt F, Volpel B, Obermaier-Kusser B, Horvath R. A mutation in mttRNALeu(UUR) causing a neuropsychiatric syndrome with depression and cataract. Neurology 2001;57:1930-1.
20. Raspall-Chaure M, Solano A, Vázquez E et al.A patient with bilateral lesion in the striatum and slowly progressive dystonia secondary to T14487C mutation in the ND6 gene of complex I of the mitochondrial respiratory chain. Rev Neurol 2004;39:1129-32.
21. Taylor RW, Singh-Kler R, Hayes CM, Smith PE, Turnbull DM. Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol 2001;50:104-7.
22. Carod-Artal FJ, Herrero MD, Lara MC et al.Cognitive dysfunction and hypogonadotrophichypogonadism in a Brazilian patient with mitochondrial neurogastrointestinalencephalomyopathy and a novel ECGF1 mutation. Eur J Neurol 2007;14:581-5.
23. Lin J, ChiconelliFaria E, Da Rocha AJ et al.Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J Child Neurol 2010;25:1425-8.
24. Scheper GC, van der Klok T, van Andel RJ et al.Mitochondrial aspartyl-tRNAsynthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007;39:534-9.
25. Gramstad A, Bindoff LA, Lillebø A, Tzoulis C, Engelsen BA. Neuropsychological performance in patients with POLG1 mutations and the syndrome of mitochondrial spinocerebellar ataxia and epilepsy. Epilepsy Behav 2009;16:172-4.
26. Hakonen AH, Heiskanen S, Juvonen V et al.Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005;77:430-41.
27. Van Goethem G, Luoma P, Rantamäki M et al.POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004;63:1251-7.
28. Van Hove JL, Cunningham V, Rice C et al.Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of TWINKLE-related dominant disease. Am J Med Genet A 2009;149A:861-7.
29. Bahmad F Jr, Merchant SN, Nadol JB Jr, Tranebjaerg L. Otopathology in Mohr-Tranebjaerg syndrome. Laryngoscope 2007;117:1202-8.
30. Grafakou O, Oexle K, van den Heuvel L et al.Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation. Eur J Pediatr 2003;162:714-8.
31. Nickl-Jockschat T, Kunert HJ, Herpertz-Dahlmann B, Grözinger M. Psychiatric symptoms in a patient with Wolfram syndrome caused by a combination of thalamic deficit and endocrinological pathologies. Neurocase 2008;15:47-52.
32. Fisch GS, Grossfeld P, Falk R, Battaglia A, Youngblom J, Simensen R. Cognitive-behavioral features of Wolf-Hirschhorn syndrome and other subtelomericmicrodeletions. Am J Med Genet C Semin Med Genet 2010;154C:417-26.
33. Seeger J, Schrank B, Pyle A et al.Clinical and neuropathological findings in patients with TACO1 mutations. Neuromuscul Disord 2010;20:720-4.
34. Pérez López-Fraile MI, Barrena R, Montoya J, Marta E. Evolution until death of two members of a family with A3243G mutation and MELAS phenotype versus diabetes mellitus. Neurologia 2006;21:327-32.
35. Finsterer J, Segall L. Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 2010;33:138-51.
36. Berg RM, Møller K, Bailey DM. Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab 2011;31:1532-44.
37. Finsterer J. Chronic anemia as a manifestation of MELAS syndrome. Rev Invest Clin 2011;63:100-3.
38. Kaufmann P, Shungu DC, Sano MC et al.Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004;62:1297-302.
39. Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008;1142:133-58.
40. Coomans H, Barroso B, Bertandeau E et al.Mutism and acute behavioral disorders revealing MELAS syndrome. Rev Neurol (Paris) 2011;167:847-51.
41. Lorenzoni PJ, Scola RH, Kay CS, Arndt RC, Silvado CE, Werneck LC. MERRF: clinical features, muscle biopsy and molecular genetics in Brazilian patients. Mitochondrion 2011;11:528-32.
42. Mayer WJ, Remy M, Rudolph G. Kearns-Sayre syndrome: a mitochondrial disease (OMIM #530000). Ophthalmologe 2011;108:459-62.
43. Gelfand JM, Duncan JL, Racine CA et al.Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol 2011;258:440-8.
44. Lien LM, Lee HC, Wang KL, Chiu JC, Chiu HC, Wei YH. Involvement of nervous system in maternally inherited diabetes and deafness (MIDD) with the A3243G mutation of mitochondrial DNA. Acta Neurol Scand 2001;103:159-65.
45. Schüpbach WM, Vadday KM, Schaller A et al.Mitochondrial neurogastrointestinalencephalomyopathy in three siblings: clinical, genetic and neuroradiological features. J Neurol 2007;254:146-53.
46. Ponjavic V, Andreasson S, Tranebjaerg L, Lubs HA. Full-field electroretinograms in a family with Mohr-Tranebjaerg syndrome. Acta Ophthalmol Scand 1996;74:632-5.
47. Tranebjaerg L, Schwartz C, Eriksen H et al. A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet 1995;32:257-63.
48. Binder J, Hofmann S, Kreisel S et al. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. Brain 2003;126:1814-20.
49. Del Bo R, Moggio M, Rango M et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 2008;71:1959-66.
50. Bourgeois M, Duret A, Vital C, Assens F, Mazerat P. Leigh disease in an adult. A case with psychiatric symptoms. Ann Med Psychol (Paris) 1986;144:485-94.
51. Koga Y, Povalko N, Katayama K et al. Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene. Brain Dev 2012;34:87-91.